The Valley Desk

NCT04273945 · Interventional trial

Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

Overall registry status Active not recruiting

Phase 3

Conditions Pulmonary Arterial Hypertension

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov